Position in INSM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,781,491
-$1,883,004 QoQ
Shares Held
35,467
+2.4% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#229
of 663 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 78%
Shared 0%
None 22%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Orion Porfolio Solutions, LLC holds $65,856,861 across 60 Biotechnology names. INSM ranks #4 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,853 | $5,887,740 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
23,454 | $5,651,710 | |
| 3 | RPRX |
Royalty Pharma plc
|
99,319 | $5,568,816 | |
| 4 | INSM |
INSMED Inc
This page
|
35,467 | $3,781,491 | |
| 5 | ARGX |
Argenx SE
|
2,471 | $2,292,519 | |
| 6 | INVA |
Innoviva, Inc.
|
92,707 | $2,105,375 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
24,870 | $1,971,942 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
3,491 | $1,874,492 |
All Filings in INSM
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,781,491 | 35,467 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $5,664,495 | 34,641 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $6,367,427 | 36,586 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $5,284,158 | 36,693 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $4,208,462 | 41,817 | Shares | Sole | 2025-08-27 | |
| 2025-03-31 | $2,955,093 | 38,735 | Shares | Sole | 2025-08-01 | |
| 2024-12-31 | $1,916,688 | 27,762 | Shares | Sole | 2025-08-01 | |
| 2024-09-30 | $2,050,351 | 28,087 | Shares | Sole | 2025-07-31 | |
| 2024-06-30 | $1,267,439 | 18,917 | Shares | Sole | 2025-07-31 | |
| No filing history on record for this holder in this stock. | ||||||